Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients.

More about this publication

Annals of oncology : official journal of the European Society for Medical Oncology
  • Volume 30
  • Issue nr. 5
  • Pages 663-665
  • Publication date 01-05-2019

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.